• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于乳房重建的脱细胞真皮基质厚度和方向的结果评估。

Outcome Assessment According to the Thickness and Direction of the Acellular Dermal Matrix after Implant-Based Breast Reconstruction.

机构信息

Department of Plastic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

出版信息

Biomed Res Int. 2021 Nov 16;2021:8101009. doi: 10.1155/2021/8101009. eCollection 2021.

DOI:10.1155/2021/8101009
PMID:34825003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8610697/
Abstract

PURPOSE

The acellular dermal matrix plays an important role in reinforcing thin mastectomy skin and repositioning the implant in prosthetic breast reconstruction. As the concept of prepectoral plane has become widespread, the role of the acellular dermal matrix has become increasingly important. However, evidences and standards for appropriate thickness and direction during placement remain insufficient. This study is aimed at testing the assumption that differences in the acellular dermal matrix thickness and orientation during placement may affect surgical outcomes including the incidence of postoperative complications.

METHODS

This was a retrospective single-centered analysis of 43 patients (50 breasts) who underwent implant-based reconstruction with MegaDerm® (L&C Bio, Seoul, Korea) and 23 patients (23 breasts) who underwent implant-based reconstruction with DermACELL® (LifeNet Health, Virginia Beach, VA, USA), two types of human-derived acellular dermal matrix. All surgeries were performed by a single surgeon. Demographic variables, surgery-related factors, and complications were compared between a thick matrix group (1.5-2.3 mm) and a thin matrix group (1.0-1.5 mm). The same processes were performed in the nonreverse and reverse matrix insertion groups.

RESULTS

Baseline demographics and surgery-related data were summarized according to matrix thickness and direction. There were no significant intergroup differences in the demographic variables such as history of smoking, radiation, or chemotherapy. The mean drain volume was significantly higher in the thick matrix group than that in the thin matrix group ( = 0.0445). However, there were no significant differences in overall complication rates by matrix thickness ( = 0.3139). Additionally, there were no significant differences in complications between the nonreverse and reverse matrix insertion groups ( = 0.538).

CONCLUSION

Our findings suggest that patients with a thick acellular dermal matrix need a prolonged period for engraftment. However, the thickness did not directly affect the surgical outcomes between the thick and thin matrix groups. Likewise, the orientation in which the acellular dermal matrix was inserted did not affect the surgical outcomes including postoperative complications.

摘要

目的

脱细胞真皮基质在加强薄型乳房切除术皮肤和重新定位假体乳房重建中的植入物方面发挥着重要作用。随着胸肌前平面概念的普及,脱细胞真皮基质的作用变得越来越重要。然而,在放置过程中适当的厚度和方向的证据和标准仍然不足。本研究旨在检验以下假设,即放置过程中脱细胞真皮基质的厚度和方向的差异可能会影响手术结果,包括术后并发症的发生率。

方法

这是一项对 43 名患者(50 只乳房)进行的回顾性单中心分析,这些患者接受了基于植入物的重建,使用的是 MegaDerm®(韩国首尔的 L&C Bio),以及 23 名患者(23 只乳房)接受了基于植入物的重建,使用的是 DermACELL®(弗吉尼亚海滩的 LifeNet Health,VA,美国),这两种都是人体衍生的脱细胞真皮基质。所有手术均由同一位外科医生完成。比较厚基质组(1.5-2.3mm)和薄基质组(1.0-1.5mm)之间的人口统计学变量、手术相关因素和并发症。在非反转和反转基质插入组中进行了相同的过程。

结果

根据基质厚度和方向总结了基线人口统计学和手术相关数据。在吸烟、放疗或化疗史等人口统计学变量方面,各组间无显著差异。厚基质组的平均引流量明显高于薄基质组( = 0.0445)。然而,基质厚度对总并发症发生率无显著差异( = 0.3139)。此外,非反转和反转基质插入组之间的并发症无显著差异( = 0.538)。

结论

我们的研究结果表明,厚脱细胞真皮基质的患者需要更长的时间进行植入。然而,厚度并没有直接影响厚基质组和薄基质组之间的手术结果。同样,脱细胞真皮基质插入的方向也不会影响手术结果,包括术后并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c26/8610697/0a9a4c03940d/BMRI2021-8101009.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c26/8610697/647ed8b15467/BMRI2021-8101009.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c26/8610697/028626526254/BMRI2021-8101009.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c26/8610697/0a9a4c03940d/BMRI2021-8101009.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c26/8610697/647ed8b15467/BMRI2021-8101009.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c26/8610697/028626526254/BMRI2021-8101009.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c26/8610697/0a9a4c03940d/BMRI2021-8101009.003.jpg

相似文献

1
Outcome Assessment According to the Thickness and Direction of the Acellular Dermal Matrix after Implant-Based Breast Reconstruction.基于乳房重建的脱细胞真皮基质厚度和方向的结果评估。
Biomed Res Int. 2021 Nov 16;2021:8101009. doi: 10.1155/2021/8101009. eCollection 2021.
2
Impact of Dermal Matrix Brand in Implant-Based Breast Reconstruction Outcomes.真皮基质品牌对基于假体的乳房重建结果的影响。
Plast Reconstr Surg. 2022 Jul 1;150(1):17-25. doi: 10.1097/PRS.0000000000009178. Epub 2022 May 2.
3
From Salvage to Prevention: A Single-Surgeon Experience with Acellular Dermal Matrix and Infection in Prepectoral Breast Reconstruction.从挽救到预防:单一外科医生在胸肌前置乳房重建中使用脱细胞真皮基质和预防感染的经验。
Plast Reconstr Surg. 2021 Dec 1;148(6):1201-1208. doi: 10.1097/PRS.0000000000008519.
4
Direct-to-Implant, Prepectoral Breast Reconstruction: A Single-Surgeon Experience with 201 Consecutive Patients.直接置管入胸假体乳房重建:单外科医生 201 例连续患者的经验。
Plast Reconstr Surg. 2020 Apr;145(4):686e-696e. doi: 10.1097/PRS.0000000000006654.
5
Acellular Dermal Matrix-Associated Complications in Implant-Based Breast Reconstruction: A Multicenter, Prospective, Randomized Controlled Clinical Trial Comparing Two Human Tissues.脱细胞真皮基质相关并发症在基于植入物的乳房重建中的应用:一项比较两种人组织的多中心、前瞻性、随机对照临床试验。
Plast Reconstr Surg. 2021 Sep 1;148(3):493-500. doi: 10.1097/PRS.0000000000008194.
6
Early Experience of Direct-to-Implant Breast Reconstruction Using Acellular Dermal Matrix after Robot-Assisted Nipple-Sparing Mastectomy.机器人辅助保乳术后脱细胞真皮基质在即刻乳房重建中的早期经验。
Plast Reconstr Surg. 2024 Sep 1;154(3):512-520. doi: 10.1097/PRS.0000000000011105. Epub 2023 Oct 3.
7
Review: Implant-Based Breast Reconstruction After Mastectomy for Breast Cancer: A Meta-analysis of Randomized Controlled Trials and Prospective Studies Comparing Use of Acellular Dermal Matrix (ADM) Versus Without ADM.综述:乳腺癌乳房切除术术后基于植入物的乳房重建:比较使用脱细胞真皮基质 (ADM)与不使用 ADM 的随机对照试验和前瞻性研究的荟萃分析。
Ann Surg Oncol. 2024 May;31(5):3366-3376. doi: 10.1245/s10434-024-14943-4. Epub 2024 Jan 29.
8
The Comparison of Strattice and SurgiMend in Acellular Dermal Matrix-Assisted, Implant-Based Immediate Breast Reconstruction.Strattice 与 SurgiMend 在脱细胞真皮基质辅助即刻乳房重建中应用的比较。
Plast Reconstr Surg. 2018 Feb;141(2):283-293. doi: 10.1097/PRS.0000000000004018.
9
Implant-based immediate reconstruction in prophylactic mastectomy: is the caudal dermis flap a reliable alternative to synthetic mesh or acellular dermal matrix?预防性乳房切除术的基于植入物的即刻重建:尾部真皮皮瓣是否是合成网或脱细胞真皮基质的可靠替代品?
Arch Gynecol Obstet. 2022 Apr;305(4):937-943. doi: 10.1007/s00404-021-06244-y. Epub 2021 Sep 23.
10
Acellular Dermal Matrix in Immediate Expander/Implant Breast Reconstruction: A Multicenter Assessment of Risks and Benefits.即时扩张器/植入物乳房重建中脱细胞真皮基质的多中心风险与效益评估
Plast Reconstr Surg. 2017 Dec;140(6):1091-1100. doi: 10.1097/PRS.0000000000003842.

引用本文的文献

1
Comparison of the Characteristics of Three Acellular Dermal Matrices Subjected to Distinct Processing Methods Using Five Types of Histochemical Staining.五种组织化学染色比较三种不同处理方法制备的脱细胞真皮基质的特性。
Aesthetic Plast Surg. 2023 Aug;47(4):1315-1323. doi: 10.1007/s00266-023-03318-x. Epub 2023 May 2.
2
Overview of Biologic Agents Used in Skin and Soft Tissue Reconstruction.皮肤和软组织重建中使用的生物制剂概述。
Semin Plast Surg. 2022 Feb 15;36(1):3-7. doi: 10.1055/s-0042-1742736. eCollection 2022 Feb.

本文引用的文献

1
"To Pre or Not to Pre": Introduction of a Prepectoral Breast Reconstruction Assessment Score to Help Surgeons Solving the Decision-Making Dilemma. Retrospective Results of a Multicenter Experience.“要还是不要前置”:引入一种乳房重建术前评估评分系统,帮助外科医生解决决策困境。多中心经验回顾性结果。
Plast Reconstr Surg. 2021 Jun 1;147(6):1278-1286. doi: 10.1097/PRS.0000000000008120.
2
Complication Rate of Prepectoral Implant-based Breast Reconstruction Using Human Acellular Dermal Matrices.使用人脱细胞真皮基质的胸肌前植入式乳房重建的并发症发生率
Plast Reconstr Surg Glob Open. 2020 Dec 3;8(12):e3235. doi: 10.1097/GOX.0000000000003235. eCollection 2020 Dec.
3
Prepectoral implant pocket conversion in breast reconstruction.
乳房重建中胸大肌前植入腔隙转换术
JPRAS Open. 2020 Sep 7;26:12-25. doi: 10.1016/j.jpra.2020.08.001. eCollection 2020 Dec.
4
[Suitability of biological acellular dermal matrices as a skin replacement].[生物脱细胞真皮基质作为皮肤替代物的适用性]
Handchir Mikrochir Plast Chir. 2020 Dec;52(6):533-544. doi: 10.1055/a-1200-1189. Epub 2020 Jul 30.
5
Histologic Evaluation of Acellular Dermal Matrix Allografts in Humans.人脱细胞真皮基质同种异体移植物的组织学评估
Clin Adv Periodontics. 2017 Aug;7(3):122-127. doi: 10.1902/cap.2017.160057.
6
Prepectoral breast reconstruction with TiLoop® Bra Pocket: a single center prospective study.TiLoop® 乳房补片口袋前置乳房重建:单中心前瞻性研究。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):991-999. doi: 10.26355/eurrev_202002_20149.
7
Multicentre study of prepectoral breast reconstruction using acellular dermal matrix.多中心研究使用脱细胞真皮基质的胸肌前乳房重建。
BJS Open. 2020 Feb;4(1):71-77. doi: 10.1002/bjs5.50236. Epub 2019 Dec 19.
8
Acellular Dermal Matrix, the Breast, and the FDA.脱细胞真皮基质、乳房与美国食品药品监督管理局
Plast Reconstr Surg. 2020 Feb;145(2):463e-464e. doi: 10.1097/PRS.0000000000006486.
9
Skin-Reducing Mastectomy and Pre-pectoral Breast Reconstruction in Large Ptotic Breasts.皮肤缩减乳房切除术和大型乳房下垂前乳房重建。
Aesthetic Plast Surg. 2020 Jun;44(3):664-672. doi: 10.1007/s00266-020-01616-2. Epub 2020 Jan 22.
10
Considerations for patient selection: Prepectoral versus subpectoral implant-based breast reconstruction.患者选择的考量因素:胸大肌前与胸大肌下植入式乳房重建
Arch Plast Surg. 2019 Nov;46(6):550-557. doi: 10.5999/aps.2019.00353. Epub 2019 Nov 15.